Pharmacies must pay $650.6 million to Ohio counties in opioid case

Pharmacies must pay 0.6 million to Ohio counties in opioid case


A customer views merchandise for sale at a Walgreens store in the Hollywood neighborhood of Los Angeles.

Christopher Lee | Bloomberg | Getty Images

Pharmacy operators CVS, Walmart and Walgreens must pay a combined $650.6 million to two Ohio counties to address the damage done by the opioid epidemic, a federal judge ruled on Wednesday.

The order by U.S. Judge Dan Polster in Cleveland comes after a jury last November concluded that the pharmacy chains helped create a public nuisance in Lake and Trumbull counties by over-supplying addictive pain pills, many of which found their way onto the black market. The pharmacies have said they would appeal that verdict.

Polster held a separate non-jury trial earlier this year to decide how much the companies had to pay.

“We are disappointed with this outcome,” Walgreens spokesman Fraser Engleman said in a statement. “The facts and the law did not support the jury verdict last fall, and they do not support the court’s decision now.”

CVS and Walmart did not immediately respond to requests for comment.

Polster said the sum must be paid over 15 years, with the amount for the first two years, or $86.7 million, to be paid into a fund immediately. The judge also ordered the companies to implement new procedures to combat illegal diversion of opioid drugs.

The U.S. opioid epidemic has caused more than 500,000 overdose deaths over two decades, according to government data. More than 3,300 opioid lawsuits have been filed nationally against drugmakers, distributors and pharmacy chains.

The litigation has resulted in several nationwide settlements, including a $26 billion deal with Johnson & Johnson and the three leading distributors, a $2.37 billion settlement with AbbVie Inc and a $4.25 billion settlement with Teva Pharmaceutical Industries Ltd.

Pharmacies have yet to reach a nationwide settlement.



Source

Jim Cramer has faith in Danaher’s turnaround as life sciences comes back to life
Health

Jim Cramer has faith in Danaher’s turnaround as life sciences comes back to life

Life sciences stocks are seeing a resurgence — and that’s good news for Danaher . Connecting the dots to better times ahead for the struggling portfolio name, Jim Cramer thinks the industry turnaround is best illustrated by looking at Agilent Technologies ‘ recovery from a post-Covid rut. Shares are up around 50% from their April […]

Read More
‘Advice was so good,’ says CEO who used ChatGPT to pitch new ideas to AI versions of business icons
Health

‘Advice was so good,’ says CEO who used ChatGPT to pitch new ideas to AI versions of business icons

Joanna Stober, Midi Health CEO and co-founder, has never had an opportunity to run her business plans past legendary venture capital investor John Doerr, chairman at Kleiner Perkins. But that didn’t stop her from tapping Doerr, in an AI version, for advice on growing her startup, a virtual clinic offering midlife health care for women. […]

Read More
Eli Lilly cuts cash prices of Zepbound weight loss drug vials on direct-to-consumer site
Health

Eli Lilly cuts cash prices of Zepbound weight loss drug vials on direct-to-consumer site

The Eli Lilly logo appears on the company’s office in San Diego, California, U.S., Nov. 21, 2025. Mike Blake | Reuters Eli Lilly on Monday said it is lowering the cash prices of single-dose vials of its blockbuster weight loss drug Zepbound on its direct-to-consumer platform, LillyDirect, building on efforts by the company and the […]

Read More